The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...

The deep-learning model used the whole “breast architecture,” not just calcification, to predict MACE risk in middle-aged ...

Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the medication within a year, according to a large population-based study out of ...